Double-blind study to understand the effects of psylocibin in decreasing symptoms of anxiety, depression and other mood disorders
Double-blind study design:
- Low-dose group
- High-dose group
- Administration at Baseline, 5 weeks after session 2, and a 6-month follow-up
- Control for physiological measures to establish a risk assesment
0
1
Tags
Behavioral Neuroscience
Psychology
Neuroscience (Neurobiology)
Social Science
Empirical Science
Science
Life Science / Biology
Biomedical Sciences
Natural Science
Health Psychology
SARS-CoV-2 (COVID-19)
Related
Psilocybin produces substantial and sustained decreases in depression and anxiety in patients with life-threatening cancer: A randomized double-blind trial
Chronic development of depressive and anxiety symptoms in patients with terminal diseases
Advantages of psilocybin use in psycho-therapy
Double-blind study to understand the effects of psylocibin in decreasing symptoms of anxiety, depression and other mood disorders
Learn After
Low-dose group in a double-blind study of psilocybin's effects in depressive and anxiety symptoms
Low-dose group in psilocybin double-blind study
High-dose group in psilocybin double-blind study
6 month follow-up in psilocybin double-blind study
Control of physiological measures in psilocybin double-blind study